Information and communication

It is NattoPharma's policy that all shareholders shall be treated equally as far as access to information relevant to evaluating and valuing the company is concerned, and that the company will receive and evaluate the shareholders' points of view and interest in the company's operations, result and strategies. NattoPharma strives to present accounts and other financial reporting in which investors can have full confidence and which satisfy the requirements of the Oslo Stock Exchange for listed companies. NattoPharma's accounting practices indicate a high degree of transparency and are based on the IFRS standard. Up-to-date financial information and other company related information is published on the company's website.

The company has not adopted guidelines for the company's contact with shareholders outside the annual general meeting, but is working on establishing these.

A financial calendar is available on the Company’s web-site.

Information sent to the shareholders is simultaneously posted on the Company’s web-site.

Contact Us

NattoPharma ASA
(head office)
Lilleakerveien 2B
0283 Oslo, Norway
Tel: (+47) 40 00 90 08

NattoPharma USA, Inc.
(North American Subsidiary)
328 Amboy Avenue, Ste. D
Metuchen, NJ 08840, USA
Tel: (+1) 609-454-2992

NattoPharma contact information:
Main office: Lilleakerveien 2B, 0283 Oslo,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+47) 40 00 90 08
Tel: (+1) 609-454-2992
Created by:
Nutricon logo.
Search term: